Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

MPA increases cancer spread by boosting Eph A2 activity.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Adalimumab may cause severe hair loss in some patients.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Methotrexate is not proven to maintain remission in ulcerative colitis.

The scaffold effectively prevents melanoma relapse and aids wound healing.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

M50054 may help treat hepatitis and hair loss from chemotherapy.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

Co-trimoxazole may help treat autoimmune diseases.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Baricitinib is more effective than methotrexate for severe alopecia areata.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

The treatment was ineffective in humans.